 |
Gur
Roshwalb, M.D.
Education
B.A., Columbia University, New York
M.B.A., Leonard N. Stern School of Business, New York, Beta Gamma Sigma
M.D., Albert Einstein College of Medicine, New York
|
Gur joined Venrock in 2008. Prior to joining Venrock, he was a vice president and senior research analyst at Piper Jaffray & Co., focusing on specialty pharmaceuticals and small cap biotech companies. In this role, Gur was responsible for analyzing, valuing and publishing research on both publicly traded and privately held biotech and specialty pharmaceutical companies. Gur was trained in internal medicine at the Mount Sinai Medical Center, New York, where he also served as chief resident, and subsequently spent several years in private practice as an internist in New York.
|
